-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Serje ta' aċidu amminiku |Fmoc-3-(2-Naphthyl)-L-alanine |CAS:112883-43-9 |C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Fmoc-Trp(Boc)-OH |CAS:143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Serje ta' aċidu amminiku |Fmoc-L-Leucine |CAS:35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Serje ta' aċidu amminiku |Fmoc-D-leucine |CAS:114360-54-2 |C21H23NO4
-
![N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3](https://www.yisunbio.com/uploads/281.jpg)
N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |CAS:1202003-49-3 |C27H34N2O6
-
![O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine |CAS:1013883-02-7 |C31H34N2O7
-
Aċidu hippuriku 495-69-2
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu hippuriku |CAS:495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Kimiċi |Materja Prima Kimika |Intermedju farmaċewtiku industrijali |Kardjovaskulari |Trattament ta' pressjoni għolja |Valsartan Intermedji |Valsartan |CAS:137862-53-4 |C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Kimiċi |Materja Prima Kimika |Intermedju farmaċewtiku industrijali |Kardjovaskulari |Valsartan Intermedji |L-Valine methyl ester hydrochloride |CAS:6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Kimiċi |Materja Prima Kimika |Intermedju farmaċewtiku industrijali |Kardjovaskulari |Trattament ta' pressjoni għolja |Valsartan Intermedji |N-[(2'-Cyano[1,1'-bifenil]-4-il)metil]-L-valine methyl ester hydrochloride |CAS:482577-59-3 |C20H22N2O2.HCl
-
Valsartan metil ester 137863-17-3
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Kimiċi |Materja Prima Kimika |Intermedju farmaċewtiku industrijali |Kardjovaskulari |Trattament ta' pressjoni għolja |Valsartan Intermedji |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine metil ester |CAS:137863-17-3 |C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Farmaċewtiċi Intermedji |Mard infettiv |Dermatoloġiku |Luliconazole Intermedji |(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethano |CAS:126534-31-4 |C8H7Cl3O